Lind Global Fund II LP 13D and 13G filings for Vallon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 4:30 pm Sale | 2022-12-31 | 13G | Vallon Pharmaceuticals, Inc. VLON | Lind Global Fund II LP | 250 0.100% | -35,900 (-99.31%) | Filing |
| 2022-05-23 5:00 pm Purchase | 2022-05-17 | 13G | Vallon Pharmaceuticals, Inc. VLON | Lind Global Fund II LP | 36,150 9.900% | 36,150 (New Position) | Filing |